| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.22 | 0.05 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |